Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Lineage Cell Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 129 | 112 | −17 |
| Shares | 97.8M | 87.9M | −9.85M (−10.1%) |
| Value | $88.4M | $148.6M | +$60.2M (+68.2%) |
New holders (17)
Institutions that held Lineage Cell Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EAM Investors, LLC | 442,221 | $747.4K | 0.09% |
| Quadrature Capital Ltd | 179,031 | $304.4K | 0.00% |
| Jefferies Financial Group Inc. | 62,200 | $105.1K | 0.00% |
| Equitable Holdings, Inc. | 30,024 | $50.7K | 0.00% |
| Simplex Trading, LLC | 28,017 | $47.0K | 0.00% |
| Catalytic Wealth RIA, LLC | 18,714 | $31.6K | 0.00% |
| Citizens Financial Group Inc | 15,000 | $25.4K | 0.00% |
| R Squared Ltd | 11,823 | $20.0K | 0.01% |
| GWM Advisors LLC | 11,500 | $19.4K | 0.00% |
| Kestra Advisory Services, LLC | 10,100 | $17.1K | 0.00% |
| Beverly Hills Private Wealth, LLC | 10,000 | $16.9K | 0.00% |
| Rockefeller Capital Management L.P. | 5,478 | $9.26K | 0.00% |
| TD Waterhouse Canada Inc. | 1,500 | $2.56K | 0.00% |
| Northwestern Mutual Wealth Management Co | 888 | $1.50K | 0.00% |
| SRS Capital Advisors, Inc. | 118 | $199 | 0.00% |
| Wealthspire Advisors, LLC | 88 | $149 | 0.00% |
| Steward Partners Investment Advisory, LLC | 11 | $19 | 0.00% |
Sold out (34)
Institutions that held Lineage Cell Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.